Lucie Ecker

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 170 citations · Full text

Factors Affecting Caregivers’ Use of Antibiotics Available Without a Prescription in Peru

Lucie Ecker, Theresa J. Ochoa, Martha Vargas et al. · PEDIATRICS · 2013 · 38 citations

Quantitative Real-time Polymerase Chain Reaction for Enteropathogenic Escherichia coli: A Tool for Investigation of Asymptomatic Versus Symptomatic Infections

Francesca Barletta, Theresa J. Ochoa, Erik H. Mercado et al. · Greater South Information System · 2011 · 35 citations · Full text

Safety and Immunogenicity of an Investigational Fully Liquid Hexavalent DTaP-IPV-Hep B-PRP-T Vaccine at Two, Four and Six Months of Age Compared With Licensed Vaccines in Latin America

M. Macías, Claudio F. Lanata, Betzana Zambrano et al. · The Pediatric Infectious Disease Journal · 2012 · 35 citations

Immunogenicity and Safety of a Fully Liquid DTaP-IPV-Hep B-PRP-T Vaccine at 2-4-6 Months of Age in Peru

Claudio F. Lanata, Betzana Zambrano, Lucie Ecker · Journal of Vaccines & Vaccination · 2012 · 26 citations · Full text